NO902600L - Fremgangsmaate og mellomprodukt for fremstilling av tigogenin beta-cellobiosid. - Google Patents

Fremgangsmaate og mellomprodukt for fremstilling av tigogenin beta-cellobiosid.

Info

Publication number
NO902600L
NO902600L NO90902600A NO902600A NO902600L NO 902600 L NO902600 L NO 902600L NO 90902600 A NO90902600 A NO 90902600A NO 902600 A NO902600 A NO 902600A NO 902600 L NO902600 L NO 902600L
Authority
NO
Norway
Prior art keywords
cellobioside
preparation
tigogenin
beta
tigogenin beta
Prior art date
Application number
NO90902600A
Other languages
English (en)
Other versions
NO902600D0 (no
Inventor
Frank John Urban
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO902600D0 publication Critical patent/NO902600D0/no
Publication of NO902600L publication Critical patent/NO902600L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Catalysts (AREA)
  • Compounds Of Unknown Constitution (AREA)
NO90902600A 1989-06-13 1990-06-12 Fremgangsmaate og mellomprodukt for fremstilling av tigogenin beta-cellobiosid. NO902600L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/365,588 US5010185A (en) 1989-06-13 1989-06-13 Processes for tigogenin beta-cellobioside

Publications (2)

Publication Number Publication Date
NO902600D0 NO902600D0 (no) 1990-06-12
NO902600L true NO902600L (no) 1990-12-14

Family

ID=23439483

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90902600A NO902600L (no) 1989-06-13 1990-06-12 Fremgangsmaate og mellomprodukt for fremstilling av tigogenin beta-cellobiosid.

Country Status (23)

Country Link
US (1) US5010185A (no)
EP (1) EP0403150B1 (no)
JP (1) JPH0637514B2 (no)
KR (1) KR920002146B1 (no)
AT (1) ATE114155T1 (no)
AU (1) AU619986B2 (no)
CA (1) CA2018722A1 (no)
CZ (1) CZ279909B6 (no)
DD (1) DD295164A5 (no)
DE (1) DE69014152T2 (no)
DK (1) DK0403150T3 (no)
ES (1) ES2063269T3 (no)
FI (1) FI902937A7 (no)
HU (1) HU210689B (no)
IE (1) IE64057B1 (no)
IL (1) IL94650A (no)
NO (1) NO902600L (no)
NZ (1) NZ234028A (no)
PL (3) PL163219B1 (no)
PT (1) PT94337A (no)
RU (1) RU2042688C1 (no)
YU (1) YU47515B (no)
ZA (1) ZA904527B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294703A (en) * 1992-05-01 1994-03-15 Eastman Kodak Company Process for preparing α-D-cellobiose octaacetate
CZ331094A3 (en) * 1992-06-26 1995-09-13 Pfizer Steroidal glycosides and their use for treating hypercholesterolemia and atherosclerosis
JP2578399B2 (ja) * 1992-06-26 1997-02-05 ファイザー インク． ステロイド−β−Ｏ−セロビオシドヘプタアルカノエートの製造方法
DK0647235T3 (da) * 1992-06-26 1997-10-27 Pfizer Fremgangsmåde til steroide peracylglycosider
US5530107A (en) * 1992-10-15 1996-06-25 Pfizer Inc. Method for making steroidal peracyl glycosides
EP0696292A1 (en) * 1993-04-28 1996-02-14 Pfizer Inc. Spirostanyl glycosidal crystalline monohydrate
US5502038A (en) * 1993-06-21 1996-03-26 Medical Research Foundation Of Oregon Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption
ES2074006B1 (es) * 1993-07-05 1996-03-16 Pfizer Glicosidos esteroidales para tratar hipercolesterolemia.
GB9806513D0 (en) * 1998-03-26 1998-05-27 Phytopharm Ltd Membrane-bound receptors
JP4589869B2 (ja) * 2002-07-12 2010-12-01 塩野義製薬株式会社 酸触媒として機能するゼオライト類似体の簡易な製造法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602003A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia
US4602005A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis

Also Published As

Publication number Publication date
CA2018722A1 (en) 1990-12-13
DE69014152D1 (de) 1994-12-22
JPH0331297A (ja) 1991-02-12
KR920002146B1 (ko) 1992-03-12
IE64057B1 (en) 1995-07-12
DD295164A5 (de) 1991-10-24
ZA904527B (en) 1992-01-29
ATE114155T1 (de) 1994-12-15
US5010185A (en) 1991-04-23
NZ234028A (en) 1991-10-25
CZ279909B6 (cs) 1995-08-16
IE902101L (en) 1990-12-13
DK0403150T3 (da) 1995-01-16
RU2042688C1 (ru) 1995-08-27
CZ289090A3 (en) 1995-04-12
DE69014152T2 (de) 1995-03-23
PL163258B1 (pl) 1994-02-28
NO902600D0 (no) 1990-06-12
IE902101A1 (en) 1991-01-02
PL163259B1 (pl) 1994-02-28
EP0403150A2 (en) 1990-12-19
HU210689B (en) 1995-06-28
EP0403150B1 (en) 1994-11-17
KR910000779A (ko) 1991-01-30
PL285593A1 (en) 1991-07-01
JPH0637514B2 (ja) 1994-05-18
AU619986B2 (en) 1992-02-06
IL94650A (en) 1994-11-11
FI902937A0 (fi) 1990-06-12
FI902937A7 (fi) 1990-12-14
PL289136A1 (en) 1992-02-24
YU47515B (sh) 1995-10-03
PL163219B1 (pl) 1994-02-28
HU903816D0 (en) 1990-11-28
IL94650A0 (en) 1991-04-15
YU114590A (en) 1991-10-31
AU5707990A (en) 1991-08-01
PT94337A (pt) 1991-02-08
ES2063269T3 (es) 1995-01-01
PL289135A1 (en) 1992-02-24
HUT54708A (en) 1991-03-28
EP0403150A3 (en) 1992-06-17

Similar Documents

Publication Publication Date Title
DE122004000017I1 (de) Monoklonaler Antik¦rper gegen ein Cytotoxin, denselben erzeugendes Hybridoma und Verfahren f}r die Herstellung des gereinigten Cytotoxin.
DE69007764D1 (de) Packungsmaterial für umgekehrte Phasechromatographie und Verfahren zu dessen Herstellung.
DE69111696D1 (de) Polyimid-Kompositmaterial und Verfahren zu dessen Herstellung.
DE59003581D1 (de) Hochtemperatur-Verbund-Werkstoff, Verfahren zu seiner Herstellung sowie dessen Verwendung.
EP1022283A4 (en) NOVEL LIGNIN DERIVATIVE, MOLDINGS PRODUCED USING THIS DERIVATIVE AND PREPARATION METHOD
NO902600D0 (no) Fremgangsmaate og mellomprodukt for fremstilling av tigogenin beta-cellobiosid.
DE69019474D1 (de) Veschleissbeständige Polyoxymethylenharzzusammensetzung und Verfahren für ihre Herstellung.
HU9303638D0 (en) Reagent mixtures composition for blood-test, process for production of the composition, and process for examination blood-samples of glucose-content
ATA294087A (de) Verfahren zur herstellung von 5,6-dihydroxyindol und dessen 3-alkylderivat, zwischenverbindungen und verwendung
FR2700770B1 (fr) Procédé de fabrication du 1,1,1,2-tétrafluoro-2-chloroéthane et du pentafluoroéthane.
ATE199559T1 (de) N- und o-substituierte aminophenolderivate, zwischenprodukte zu deren herstellung, deren verwendung als hydrolasesubstrate, ein entsprechendes bestimmungsverfahren und hierfür geeignetes diagnostisches mittel
DE69502571D1 (de) Prozess für die Herstellung von fermentierbarem Material
EG22746A (en) Process and intermediates for the manufacture of pyridine 2,3 dicarboxylate compounds
HUT57753A (en) Process for producing benzthiazoles usable as anthelminic and their intermediates
DE69014169D1 (de) Polstermaterial und Verfahren für dessen Herstellung.
IT8049362A0 (it) Procedimento per la produzione di 7-alcossicarbonil-6,8-dimetil-4idrossimetil-1-ftalazone e relativi prodotti intermedi
HU893637D0 (en) Process for manufacturing especially thermoisolating foamy material by means of mixing head formed for processing at least two components and working at low pressure as well as for applying this material, the mixer for carrying out the process and the isolating material manufactured by this process
HU181076B (en) Composition for fermentation or for initiating aerob femmentations,for deodorating organic waste materials,process for producing the composition and process for quick-composting organic waste materials
PT77825B (de) Neue 2-azabicyclo<2.2.1>heptan-derivate verfahren zu ihrer herstellung diese enthaltende mittel und deren verwendung sowie 2-azabicyclo/2.2.1/heptan-derivate als zwischenprodukte und verfahren zu deren herstellung
ZA848142B (en) Substituted azetidine derivatives,process for their preparation;and their use as intermediates
HUT46077A (en) Process for the microbiological production of 9alpha-hydroxy-4-androsten-3,17-dione
DE69013722D1 (de) Nichtrostende Stahlbleche für Gebäudeaussenteile und Verfahren zum Herstellen derselben.
EP0450585A3 (en) Process for the manufacture of 2-deoxy-d-threo-pentofuranosides, intermediates for their manufacture and their use
GR3001086T3 (en) Substituted dioxanones, method for preparing same and use thereof
ZA919050B (en) Process for the production of 4,5,6,7-tetrahydro-imidazo-(4,5,ljk)(1,4)-benzidiazepine-2-(1h)-thiones as well as intermediate products